269 related articles for article (PubMed ID: 19181031)
1. Antibiotic-resistant Propionibacterium acnes suppressed by a benzoyl peroxide cleanser 6%.
Leyden JJ; Wortzman M; Baldwin EK
Cutis; 2008 Dec; 82(6):417-21. PubMed ID: 19181031
[TBL] [Abstract][Full Text] [Related]
2. Effect of topical benzoyl peroxide/clindamycin versus topical clindamycin and vehicle in the reduction of Propionibacterium acnes.
Leyden JJ
Cutis; 2002 Jun; 69(6):475-80. PubMed ID: 12078851
[TBL] [Abstract][Full Text] [Related]
3. Benzoyl peroxide cleansers for the treatment of acne vulgaris: status report on available data.
Del Rosso JQ
Cutis; 2008 Nov; 82(5):336-42. PubMed ID: 19090337
[TBL] [Abstract][Full Text] [Related]
4. The effect of benzoyl peroxide 9.8% emollient foam on reduction of Propionibacterium acnes on the back using a short contact therapy approach.
Leyden JJ; Del Rosso JQ
J Drugs Dermatol; 2012 Jul; 11(7):830-3. PubMed ID: 22777224
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of benzoyl peroxide (5.3%) emollient foam and benzoyl peroxide (8%) wash in reducing Propionibacterium acnes on the back.
Leyden JJ
J Drugs Dermatol; 2010 Jun; 9(6):622-5. PubMed ID: 20645523
[TBL] [Abstract][Full Text] [Related]
6. [Acne therapy with topical benzoyl peroxide, antibiotics and azelaic acid].
Worret WI; Fluhr JW
J Dtsch Dermatol Ges; 2006 Apr; 4(4):293-300. PubMed ID: 16638058
[TBL] [Abstract][Full Text] [Related]
7. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.
Leyden JJ; Preston N; Osborn C; Gottschalk RW
J Clin Aesthet Dermatol; 2011 May; 4(5):22-6. PubMed ID: 21607190
[TBL] [Abstract][Full Text] [Related]
8. Randomized tolerability analysis of clindamycin phosphate 1.2%-tretinoin 0.025% gel used with benzoyl peroxide wash 4% for acne vulgaris.
Draelos ZD; Potts A; Alió Saenz AB;
Cutis; 2010 Dec; 86(6):310-8. PubMed ID: 21284283
[TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind comparison of a clindamycin phosphate/benzoyl peroxide gel formulation and a matching clindamycin gel with respect to microbiologic activity and clinical efficacy in the topical treatment of acne vulgaris.
Cunliffe WJ; Holland KT; Bojar R; Levy SF
Clin Ther; 2002 Jul; 24(7):1117-33. PubMed ID: 12182256
[TBL] [Abstract][Full Text] [Related]
10. Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability.
Fakhouri T; Yentzer BA; Feldman SR
J Drugs Dermatol; 2009 Jul; 8(7):657-61. PubMed ID: 19588642
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic susceptibility of Propionibacterium acnes isolated from acne vulgaris in Korea.
Song M; Seo SH; Ko HC; Oh CK; Kwon KS; Chang CL; Kim MB
J Dermatol; 2011 Jul; 38(7):667-73. PubMed ID: 21352337
[TBL] [Abstract][Full Text] [Related]
12. Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris.
Sagransky M; Yentzer BA; Feldman SR
Expert Opin Pharmacother; 2009 Oct; 10(15):2555-62. PubMed ID: 19761357
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic-resistant Propionibacterium acnes among acne patients in a regional skin centre in Hong Kong.
Luk NM; Hui M; Lee HC; Fu LH; Liu ZH; Lam LY; Eastel M; Chan YK; Tang LS; Cheng TS; Siu FY; Ng SC; Lai YK; Ho KM
J Eur Acad Dermatol Venereol; 2013 Jan; 27(1):31-6. PubMed ID: 22103749
[TBL] [Abstract][Full Text] [Related]
14. The combination formulation of clindamycin 1% plus benzoyl peroxide 5% versus 3 different formulations of topical clindamycin alone in the reduction of Propionibacterium acnes. An in vivo comparative study.
Leyden J; Kaidbey K; Levy SF
Am J Clin Dermatol; 2001; 2(4):263-6. PubMed ID: 11705253
[TBL] [Abstract][Full Text] [Related]
15. The development of antibiotic resistance in Propionibacterium acnes.
Leyden J; Levy S
Cutis; 2001 Feb; 67(2 Suppl):21-4. PubMed ID: 11236211
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy of clindamycin and benzoyl peroxide for in vivo suppression of Propionibacterium acnes.
Gans EH; Kligman AM
J Dermatolog Treat; 2002 Sep; 13(3):107-10. PubMed ID: 12227872
[TBL] [Abstract][Full Text] [Related]
17. Comparison of 2 clindamycin 1%-benzoyl peroxide 5% topical gels used once daily in the management of acne vulgaris.
Dhawan SS
Cutis; 2009 May; 83(5):265-72. PubMed ID: 19537284
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility and genetic characteristics of Propionibacterium acnes isolated from patients with acne.
Schafer F; Fich F; Lam M; Gárate C; Wozniak A; Garcia P
Int J Dermatol; 2013 Apr; 52(4):418-25. PubMed ID: 23432195
[TBL] [Abstract][Full Text] [Related]
19. Randomised controlled multiple treatment comparison to provide a cost-effectiveness rationale for the selection of antimicrobial therapy in acne.
Ozolins M; Eady EA; Avery A; Cunliffe WJ; O'Neill C; Simpson NB; Williams HC
Health Technol Assess; 2005 Jan; 9(1):iii-212. PubMed ID: 15588555
[TBL] [Abstract][Full Text] [Related]
20. A 3-step acne system containing solubilized benzoyl peroxide versus clindamycin-benzoyl peroxide.
Thiboutot D; Eichenfield L; Shalita A; Del Rosso JQ; Swinyer L; Tanghetti E; Tschen E; Parr L
Cutis; 2009 Jul; 84(1):48-55. PubMed ID: 19743725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
